MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study
- PMID: 17616439
- DOI: 10.1016/S1474-4422(07)70176-X
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study
Abstract
Background: The 2001 and 2005 McDonald criteria allow MRI evidence for dissemination in space (DIS) and dissemination in time (DIT) to be used to diagnose multiple sclerosis in patients who present with clinically isolated syndromes (CIS). In 2006, new criteria were proposed in which DIS requires at least one T2 lesion in at least two of four locations (juxtacortical, periventricular, infratentorial, and spinal-cord) and DIT requires a new T2 lesion on a follow-up scan. We applied all three criteria in a large cohort of CIS patients to assess their performance by use of conversion to clinically definite multiple sclerosis (CDMS) as the outcome.
Methods: Patients who had two MRI scans within 12 months of CIS onset were identified in four centres in the Magnims European research network. The specificity and sensitivity of MRI criteria for CDMS after 3 years was assessed in 208 patients. A Cox proportional hazards model was applied in a larger cohort of 282 patients that included all patients irrespective of length of follow-up.
Findings: The specificity of all criteria for CDMS was high (2001 McDonald, 91%; 2005 McDonald, 88%; new, 87%). Sensitivity of the new (72%) and 2005 McDonald (60%) criteria were higher than the 2001 McDonald criteria (47%). The Cox proportional hazards model showed a higher conversion risk for all three criteria in those with both DIS and DIT than those with either DIS or DIT alone. When all three criteria were included in the model, only the new criteria had an independent significant effect on conversion risk.
Interpretation: The new criteria are simpler than the McDonald criteria without compromising specificity and accuracy. The presence of both DIS and DIT from two MRI scans has a higher specificity and risk for CDMS than either DIS or DIT alone.
Comment in
-
New MRI criteria in the diagnosis of multiple sclerosis.Lancet Neurol. 2007 Aug;6(8):664-5. doi: 10.1016/S1474-4422(07)70181-3. Lancet Neurol. 2007. PMID: 17638605 No abstract available.
-
Simplified MRI prediction of clinically definite multiple sclerosis: a stepping stone towards treatment criteria?Nat Clin Pract Neurol. 2008 Mar;4(3):136-7. doi: 10.1038/ncpneuro0730. Epub 2008 Jan 22. Nat Clin Pract Neurol. 2008. PMID: 18212786 No abstract available.
Similar articles
-
Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.Lancet Neurol. 2018 Feb;17(2):133-142. doi: 10.1016/S1474-4422(17)30469-6. Epub 2017 Dec 21. Lancet Neurol. 2018. PMID: 29275979
-
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study.Neurology. 2022 Jan 4;98(1):e1-e14. doi: 10.1212/WNL.0000000000013016. Epub 2021 Oct 29. Neurology. 2022. PMID: 34716250
-
Application of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Spanish cohort of patients with clinically isolated syndromes.Mult Scler. 2012 Jan;18(1):39-44. doi: 10.1177/1352458511417828. Epub 2011 Aug 24. Mult Scler. 2012. PMID: 21865413
-
Revised diagnostic criteria of multiple sclerosis.Autoimmun Rev. 2014 Apr-May;13(4-5):518-24. doi: 10.1016/j.autrev.2014.01.012. Epub 2014 Jan 12. Autoimmun Rev. 2014. PMID: 24424194 Review.
-
The role of MRI in the diagnosis of multiple sclerosis.Adv Neurol. 2006;98:125-46. Adv Neurol. 2006. PMID: 16400831 Review.
Cited by
-
The diagnosis of multiple sclerosis and the clinical subtypes.Ann Indian Acad Neurol. 2009 Oct;12(4):226-30. doi: 10.4103/0972-2327.58276. Ann Indian Acad Neurol. 2009. PMID: 20182569 Free PMC article.
-
Increasing the sensitivity of MRI for the detection of multiple sclerosis lesions by long axial coverage of the spinal cord: a prospective study in 119 patients.J Neurol. 2017 Feb;264(2):341-349. doi: 10.1007/s00415-016-8353-3. Epub 2016 Dec 1. J Neurol. 2017. PMID: 27909801 Clinical Trial.
-
How Common Is Signal-Intensity Increase in Optic Nerve Segments on 3D Double Inversion Recovery Sequences in Visually Asymptomatic Patients with Multiple Sclerosis?AJNR Am J Neuroradiol. 2017 Sep;38(9):1748-1753. doi: 10.3174/ajnr.A5262. Epub 2017 Jun 29. AJNR Am J Neuroradiol. 2017. PMID: 28663263 Free PMC article.
-
Comparison of diffusion-weighted imaging and contrast-enhanced T1-weighted imaging on a single baseline MRI for demonstrating dissemination in time in multiple sclerosis.BMC Neurol. 2014 May 7;14:100. doi: 10.1186/1471-2377-14-100. BMC Neurol. 2014. PMID: 24885357 Free PMC article.
-
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD006921. doi: 10.1002/14651858.CD006921.pub3. Cochrane Database Syst Rev. 2012. PMID: 23235634 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical